Biochemistry-Midterm Flashcards
1
Q
Octamer complex
A
H2A, H2B, H3, and H4 dimers
2
Q
H1 protein
A
Binds to the 30 bp linker so that the DNA doesn’t become a mess
3
Q
Denaturation of DNA is at…
A
95 degrees Celsius
4
Q
Renaturation of DNA is at…
A
37 degrees Celsius
5
Q
Melting temperature
A
Temperature at which half of the DNA is denatured
6
Q
Hybridization
A
Uses renaturation and denaturation to see how similar the genetic material of two species is
7
Q
Polymerase chain reaction (PCR)
A
Uses denaturation and renaturation to amplify a target sequence to make a specific protein
8
Q
Introns
A
In between exons
9
Q
Origin of replication (ori)
A
Full of AT rich sequences
10
Q
DNAa
A
Binds to the ori and stretches it to break the hydrogen bonds
11
Q
Helicase
A
Unwinds the DNA by breaking the hydrogen bonds
12
Q
Single strand binding proteins (SSBP)
A
Binds to the unwound strands so that they won’t get back together. Also protects genetic material from being degraded by nucleases
13
Q
Primase
A
Synthesizes the RNA primer
14
Q
Integrase
A
Helps paste the DNA transposon to the new location
15
Q
Topoisomerase I
A
Relieves stress of the supercooled DNA on one strand by cutting, unwinding, and resealing
16
Q
Topoisomerase II
A
Helps relieve stress on the supercoiled DNA on both strands by cutting, unwinding, and resealing
17
Q
DNA polymerase III
A
A holoenzyme consisting of 10 subunits. Includes:
5’-3’ polymerase
3’-5’ exonuclease
18
Q
5’-3’ polymerase
A
Adds nucleotides to the growing strand
19
Q
3’-5’ exonuclease
A
Proofreads DNA to check for errors
20
Q
Leading strand
A
Needs one RNA primer and goes towards the replication fork
21
Q
Lagging strand
A
Needs multiple RNA primers and goes way from the replication fork. Segments are discontinuous and are called Okazaki fragments
22
Q
Replication bubble/fork
A
Y-shaped opening that opens up the DNA to being replication
23
Q
DNA polymerase I
A
Works on the lagging strand after DNA polymerase III adds nucleotides
24
Q
5’-3’ exonuclease
A
Gets rid of the RNA primers on the lagging strand
25
Ligase
Joins the discontinuous fragments
26
Polymerase alpha
Primase in eukaryotes
27
Polymerase epsilon
Synthesizes the leading strand and fills in the gaps in between the primers on the lagging strand
28
Polymerase delta
Synthesizes the lagging strand
29
RNase and flap endonuclease 1 (FEN1)
Removes the primers
30
Tandem (satellite)
Repeated sequences right next to each other
31
Interspersed (transposons)
Respected at different sections of the DNA
32
Telomeres don’t shorten in...
Cancer, germ, and stem cells
33
Didanosine
Analog of adenine that fails to form a phosphodiester bond since it has H instead of OH. HIV/AIDs drug
34
Azidothymidine (AZT)
Analog of thymine that has an acidosis group instead of an OH. Doesn’t form a phosphodiester bond and is and HIV/AIDs drug
35
Camptothecin (CPT)
Inhibits topoisomerase I from binding to its site. A cancer drug
36
Eptoposide
Topoisomerase II inhibitor and a cancer drug
37
DNA polymerase proofreading errors
Mutations in the 3’ to 5’ exonuclease
38
Depurination
Removing the purines and so 3’-5’ skips over it. Results in deletion mutation
39
Deamination
Removal of amine group. Transition mutation.
Cytosine-> uracil
Guanine-> xanthine
Adenine-> hypo-xanthine
5’methylcytosine-> thymine
40
Transition mutation
Changing from purine to purine or pyrimidine to pyrimidine
41
Transversion mutation
Changing from purine to pyrimidine
42
ROS
ROS binds to DNA and damages it. 8-hydroxyl guanosine changes to thymine
43
Thymine dimers
Thymines next to each other bind and leads to structural damage
44
Point mutation
Change in one nucleotide
45
Structural damage
Breaks backbone
46
Base excision repair
Fixes deamination
47
Nucleotide excision repair
Fixes thymine diners
48
Mismatch repair
Fixes misincorporated bases. Uses MutS, MutL, and MutH
49
Missense mutation
Changes nucleotide leading to different amino acid
50
Nonsense mutation
Puts a premature stop codon
51
Frame shift mutation
Either an insertion or deletion
52
Silent mutation
Change in nucleotide but no change in amino acid coded
53
Xeroderma pigmantosium
Autosomal recessive condition where people are photosensitive. Results in mutation in nucleotide excision repair which corrects for thymine dimers
54
Ataxia-telangiectasia
Mutation in ATM gene which tells that there is an issue. Due to no correction in ROS. Degenerative motor condition due to failure to repair ROS in the cerebellum. Can’t call base excision repair system
55
Hereditary non-polyposis colon cancer (HNPCC)
Mutation in mismatch repair system
56
Restriction enzymes (endonucleases)
Cleave specific DNA sequences
57
Staggered cuts
Produces sticky ends/cohesive ends that have H bonds. Ligand can connect them together
58
Blunt cuts
Produce blunt ends that don’t have H bonds. Enzyme in the T4 bacteriophage helps ligase strands together
59
Gel electrophoresis
Electrical field in which DNA goes to the positive side (phosphates of DNA) make it negative. Separated molecules based on size
60
Requirements of PCR
Taq DNA polymerase
Two DNA primers
dNTP
Template DNA
61
3 steps of PCR
Denaturation
Annealing
Extension
62
Applications of PCR
Disease diagnosis
Disease identification
Treatment
DNA sequencing
63
Melting temperature
Tm= 2(# of A&T) + 4(# of G&C)
64
DNA sequencing
Finding out the sequencing of DNA. Two steps:
Generating the sequence
Obtaining the sequence
65
Maxam Gilbert method
Chemical process that has a lot of limitations
66
Sanger’s method
Enzymatic, dNTP, ddNTP, electrophoresis
67
Pyrosequencing
Enzymatic, dNTP, no ddNTP, no electrophoresis
68
ddNTP color
ddATP: green
ddGTP: black
ddCTP: blue
ddTTP: red
69
DNA sequencing procedure
Put all materials in PCR and amplify for 40 cycles. Clean the sample and put in electrophoresis
70
Applications of DNA sequencing
Genetic mutation
Gene function and structure
DNA cloning
71
RNA
Working copy of the DNA
72
tRNA
Makes up 15% of total RNA in the cell. Smallest RNA type in the cell. Decodes the nucleotide sequence to form amino acids at the anticodon loop
73
rRNA
Makes up 80% of total RNA in the cell.
Four different species: 28S, 18S, 5.8S, and 5 S
Attaches to ribosomal proteins
74
mRNA
Most heterogenous RNA in terms of shape and structure. Makes up 3-5% of total RNA.
Has special structures:
- 5’ cap
- 5’-3’ UTR
- poly A tail at 5’ end
75
Heterochromatin
Condensed form of DNA. Genes are inactive. HDAC removes the acetyl group from lysine to form a strong DNA/histone bond
76
Euchromatin
Less condensed structure. Has active genes. HATS adds acetyl group to the lysine to form a loose DNA/histone interaction
77
RNA polymerase I
Transcribes pre-RNA sequences of 28S, 18S, and 5.8S
78
RNA polymerase II
Transcribes mRNA and ncRNA (snRNA, miRNA, scoRNA)
79
RNA polymerase III
Transcribes tRNA and small amounts of snoRNA and snRNA
80
Promoter region
Initiates/promotes transcription
81
DNA elements
Sequences in the promoter region. Two examples:
- TATA box: 25 nucleotides upstream (down first nucleic acid)
- CAAT box: 70-89 nucleotides upstream
82
Transcription factors
Binds to the DNA elements
Example: CTF1, SP1, and TFIID (binds to TATA box)
83
Alpha-amanatin
Toxin procure by amanita phaloides mushroom. Binds to RNA polymerase II and is irreversible.
Causes GI disturbances, electrolyte imbalance, and kidney+liver dysfunction
84
45 S
Pre- RNA
85
Pre- RNA is modified by...
- Cleavage by an endonuclease (RNase)
- Trimmed by exonucleases
- Base and nucleotide modification by snoRNA
86
tRNA modifications
- 16 nucleotide sequence at 5’ end is cleaved
- 14 nucleotide sequence at anticodon loop is cleaved
- 3’ end uracil residue is converted into CCA
- Nucleotide modifications
87
Primitive mRNA
RNA polymerase II transcribes a premature RNA called heterogenous RNA (hnRNA)
88
hnRNA modifications...
- Cap at 5’ end (co)
- Poly-A tail at 3’ end (post)
- Splicing (co or post)
89
5’ Capping
Cap is a 7-methylguanosine which is added backwards frmom 5’ to 5’. Cal is not transcribed from the DNA
Stabilizes mRNA and helps in initiating translation
90
Guanylyltransferase
Adds the GMP (guanosine monophosphate)
91
7-guonosine methyltransferase
Adds the methyl group to the guanosine
92
Poly- A tail
Tail is added after it recognizes the polyadenylation sequence (AAUAAA). Tail ranges from 40-200 nucleotides.
Helps in stabilizing, in translation, and transporting out of the cell
Longer poly-A tail, more stable it is since exonucleases will have to eat more to get to the actual mRNA
Poly A tail sequence is not transcribed from the DNA
93
Polyadenylation polymerase (poly A pol)
Catalyze the poly-A tail. ATP is used as a substrates
94
Splicing
Cutting introns to only ligate the exons
95
Intron structure
5’ end: start with GU
3’ end: start with AG
Branch point A
96
snRPS
Small nuclear ribonuclear proteins. They help in splicing. Contain snRNAs
97
Splicing mechanism
2’OH of branch point A attacks 5’ end of intro closest to exon 1. This forms a 2’ to 5’ bond and lacerates it. The free 3’ end of exon 1 then binds to the 5’ of intron closest to exon 2.
98
B-knot thalesimia
Homozygous mutation in the intron region (5’ or 3’ end) in the hemoglobin gene. This totally abolishes normal splicing and is fatal!
99
B+ thalesimia
Point mutation in polyadenylation sequence. Instead of AAUAAA -> AACAAA. Less fatal
100
Epigenetic change
Modification of base pairs that leads to irreversible and hereditary changes. There is no change in bases
101
Epigenetic changes example
- The way you hold a baby
- Cellular differentiation
- Differences in monozygotic twins
102
Mice example
Normal mice has brown fur, is small, and free from disease. Agouti mice has yellow fur, is large, and prone to disease.
When give mother normal diet and B12, folate, choline, and betaine, mice were normal.
When give mother normal diet only, mice were agouti
103
Bee example
Both queen and workers have same genes. However, queen takes royal jelly diet while worker doesn’t take this diet
104
DNA methylation
Silences genes
105
DNA methyl-tansferase
Adds methyl group to 5 part of CpG cytosine.
Can measure these levels in original gene or transcribed target sequences
106
5mC inhibits gene activity because...
- Harder to break hydrogen bonds
- Larger is TFs wont attach
- Strong binding with methyl proteins so won’t bind to TFs
- Chromatin remodeling
107
Places where you can get methyl...
- Folic acid
- Betaine
- B12
- B6
- Choline
108
Importance of DNA methylation
- DNA imprinting
- X chromosome inactivation
- Aging
- Tissue specialization
109
H2A and H2B...
Leave the cell readily so not important for gene modification
110
H3 and H4...
Stats in cell and is important for gene modification
111
Histone acetylation
Charges of arginine and lysine are suppressed so genes are active
112
Histone deacetylation
Charges if arginine and lysine are activated and genes are inactive
113
Resveratol
Found in red grapes
Removes acetyl group and improves health
114
Housekeeping genes
Need them all the time.
Ex: ribosomal genes, tRNA, actin
115
Controlled genes
Need them at specific times.
Ex:histone, DNA pol, hormones
116
Regulatory DNA sequences
On the DNA and are cis acting elements (come from the same gene). Can enhance/silence gene expression
117
Regulatory proteins (TFs)
Trans-acting DNA proteins that bind to DNA elements. That activate/suppress gene expression
118
Steroid hormone receptor example
Glucocorticoid receptors are separate. When cortisol binds to the receptors, they form a protein dimer. This signals the GRE sequence to come and activate certain genes
Cortisol: DNA binding protein
GRE: DNA sequence
119
Splice site choice
Can choose what regions you want to splice
120
mRNA editing
Change in a nucleotide sequence
Ex: apoprotein B’s real form is actually really long. Change in a nucleotide sequence leads to a premature stop (missense) This protein is found in the liver and small intestine
121
In iron deficiency...
Body thinks transferrin has iron so will increase transcription of transferrin receptors while ferritin receptor transcription will decrease
122
Proto-oncogene
Normal gene. Can become cancerous by accumulation of normal protein or forming an abnormal product
123
Oncogene
Abnormal growth in cells. Can be cause by viral insertion and cellular mechanisms
124
Viral insertion
When a virus enters its genetic material into the cell, it fuses with the cells’ DNA and leads the cell to make a lot of proteins
125
Point mutation
Leads to the change in one amino acid
Ex: in RAS a point mutation leads to a change in only one amino acid
126
Amplification
Usually, when genes are amplified, they are stored in the chromosome as a double minute. Amplification leads to an increase in normal gene product.
Ex: myc oncogenes is found in many neuroblastomas
127
Chromosomal translocation
Can lead to chimeric genes
Ex: translocation between chromosome 9 & 22 leads to a fusion protein called bcr-abl that is defective in normal protein kinase
Abl protooncogene: encodes a tyrosine specific protein kinase
128
src gene
Found in the Rous Sarcoma virus and is a protein kinase tyrosine (phosphorylates tyrosine). When the oncogene is activated, it will phosphorylate other proteins as well
129
RAS gene
Encodes guanine-nucleotide binding proteins. Activity is controlled by GTP. RAS is activates by a point mutation. When activated, it will lead to enhanced signal induction though Raf-1 serine threonine kinase, ERK-1 AND ERK-2, and induction of transcription of early genes
130
Ribosomes
Place where proteins are manufactured.
Have two subunits:
- Large subunit (catalytic)-cleave
- Small subunit (decoding)- reading mRNA
Have three functional sites:
- A: place where elongator aa-tRNA will bind and form the polypeptide
- P: place where initiator aa-tRNA will bind and accepts peptidyl tRNA
- E site: where the uncharged tRNA exits
Between the A and P site, there is a hole where the protein will exit from
131
Bacterial ribosomes
30S and 50S to make 70S
132
Eukaryotic ribosomes
40S and 60S to make 80S
133
tRNA
Has unusual bases (T). Have at least 20 tRNAs for each amino acid. Has an acceptor arm (3’ end) for carrying the amino acid and an anticodon loop for decoding the mRNA.
Required for:
- Activation or polypeptide since peptide bone formation is not feasible in normal environment
- Sequencing the amino acid in the correct order
134
Initiator tRNA
Transports methionine in eukaryotes and f-met in prokaryotes. This is the first amino acid and recognizes it by the sequence AUG
135
aa-tRNA
Charging of amino acid with the correct amino acid. Completed by aa-tRNA synthetase which is a proofreading mechanism to make sure correct tRNA and amino acid are selected. Thus activates the COOH group of the amino acid.
ATP+tRNA+Amino acid->AMP+ 2pi+ aa-tRNA
136
Selecting a correct amino acid
- Size
- Thermodynamicity
- Hydrophilicity or hydrophobicity
- Acceptor arm
- C:G 3:70
- Anticodon arm
137
Double sieve mechanism
If size (so thermodynamicity) of two amino acids are similar, need to go to charge
There are two sites in aa-tRNA
- Catalytic site: hydrophobic
- Proof reading site: hydrophilic
Amino acid must go through the hydrophobic site. If it goes though the hydrophilic site, it will be thrown out
138
mRNA in prokaryotes
Has 5’ to 3’ UTR. Starts are AUG codon. No introns, capping, or poly-A tail. Translation finishes at UAA, UGA, or UAG. Initiator aa-tRNA carries f-meth
139
mRNA in eukaryotes
Has capping, poly A tail,and splicing. Cap assembles at the ribosome but translation doesn’t start until the AUG sequence is read in the Kozak sequence. Translation stops at UAA, UAG, and UGA
140
Initiation
Happens in two steps:
- Assembling the 30S subunit
- Attaching the 30S subunit with the 50S subunit
141
Assembling the 30S subunit
- IF 1 and 3 are bound to the subunit
- IF 1 blocks the A site
- IF 3 blocks site for attaching to the 50S subunit
- IF 2 and 1 take the initiator aa-tRNA and take it to P site
- IF 2 takes the initiator t-RNA and places it at the P site
142
Binding the 30S subunit to 50S subunit
When the initiator aa-tRNA is attached IF 3 disconnects to allow the 50S subunit to attach
143
Elongation
Four steps:
- Putting elongation aa-tRNA on A site
- Formation of the peptide bond
- Moving from A to P
- Moving uncharged tRNA to E site
Have different EFs for prokaryotes and eukaryotes
- Prokaryotes: eEF-1, eEFG
- Eukaryotes: EF-Tu, EF-Ts, and EFG
144
Putting elongation aa-tRNA on A site
- EF-Tu is a GTP protein and takes the elongator aa-tRNA and places it at A site. When it is put at the A site, GTP is hydrolyzed and becomes GDP. The protein is now inactive
- EF-Tu-GDP then binds to EF-Ts and displaces GDP
- EF-Tu-Ts binds to GTP and displaces Ts
145
Formation of peptide bond
Done by peptidyl transferase. Located on 23S in prokaryotes and 28S in eukaryotes. Both are located in the large subunit
146
Transferring from A to P
Use EFG (translocase) to move it from A to P.
Some antibiotics inhibit translocation which terminates translation
Antibiotics that bind to A site inhibit translation
147
Streptomycin
Binds to 16S on small subunit and prevents binding of initiator aa-tRNA to P site. Leads to polypeptide frame shift. Inhibition in initiation
148
Termination
Stop codons UAA, UAG, and UGA don’t have any tRNA association with them
- RF 1/2 will releases the polypeptide
- RF3 dissociates it and proofreads it
If a tRNA is put at a stop codon
-RF3 terminates it and RF1/2 releases it
This is post quality control
149
Streptomycin
Misreading of mRNA
150
Tetracycline
Inhibits elongation
151
Chloramphenicol (pro) or cycloheximide (euk)
Inhibits elongation
152
Erythromycin
Inhibits elongation
153
Duromycin
Inhibits elongation
154
Diphtheria toxin
Inhibits translocation
155
Protein reaches its target by...
- Targeting sequence
| - Specific modification (protein folding, glycosylation)
156
Protein modification
- Cleavage: make inactive proteins (zymogens) active. Ex: digestive enzymes, preprohormones (insulin)
- Hydroxylation: collagen
- Phosphorylation: TFs
- Lipidation: adding lipid anchors
- Glycosylation: membrane proteins and secretory proteins
157
Category 1 protein
Synthesizes entirely on the free ribosomes
Include: mitochondria, nucleus, proteosomes, and cytoplasm proteins
158
Category 2 proteins
Begins synthesis in the free ribosome and then completes it on the rER.
Includes: plasma proteins, ER and Golgi resident proteins, lysosomal proteins, and secretory proteins
159
Category 3 proteins
Synesthesia complete on the free ribosome but is then moved to the ER for post-translational modification
160
Mitochondrial proteins
Have a target sequence that is on the N-terminus. Is cleaved when the protein reaches the mitochondria
161
Nuclear proteins
Has their target sequence on the N-terminus. Is not cleaved when it reaches the nucleus
162
Proteosomal proteins
Hydrolyze fat. Have their target sequence on their C-terminus attached to Ser-Lys-Phenalalanine
163
Coupling mechanism
Signal peptide (or leading sequence) is located on N-terminus and this will be recognized by signal receptor particles (SRP). SP-SRP complex will slow down translation and bind to SRP receptor on rough ER. Once it binds, GTP will be hydrolzed. Translation will then resume
Sometimes, the signal peptide is cleaved by the ER
164
Modifications in the ER
- Glycosylation
- Oligomerization
- Quality control
- Protein folding
- Forming disulfide bridges
165
Glycosylation
N- linked Glycosylation: attaching complex carbs on the N terminus to Asn
O-linked glycosylation: attaching complex carbs on OH to Ser/Thr
166
Protein folding
Chaperones bind to the exposed hydrophobic amino acids to help fold properly
167
Quality control
If a protein is not folded properly, glucosyl tranferase will add glucosyl tranferase enzyme. A chaperone called calnexin will fold the protein correctly.
If the protein still isn’t folded correctly, will go to peroxisome.
If the protein is folded correctly, G molecule will be removed by glucosidase II and will go to Golgi
168
Modifications on the Golgi
- Terminal glycosylation
- O-linked glycosylation
- Sorting/packing
169
Sorting lysosomal proteins
Lysosomal proteins are tagged with mannose-6 phosphate and its receptor. It is exocytosed to an endosymbiosis which recycles the mannose-6 phosphate and the receptors
170
ER resident proteins
Have KDEL. When it goes to Golgi, it will have KDEL receptor to send the protein back to the ER
171
Mucolipidosis II
Accumulation of inactive lysosome and so accumulation of mucopolysaccharides in inclusion bodies (mostly in fibroblasts)
172
4 levels of protein structure
- Primary
- Secondary
- Tertiary
- Quaternary
173
Primary structure
Linear structure of amino acids that is stabilized by peptide bonds (covalent bonds)
174
Secondary structure
Stabilized by H bonds between the amino and carboxyl group.
5 forms:
- a helices
- B sheets
- B turns
- Repetitive sequences
- Motifs
175
A helices
In a right handed helix. Stabilized by H bonds between the 1st and 4th amino acid respectively.
Also have:
- a 10 helix: between every third amino acid
- Pi helix
176
B sheets
Formed by two segments of a polypeptide. If it’s formed by two polypeptides, leads to disease. R groups are up or down.
Have two sheets:
- Antiparallel: segments are coming opposite ways. Major form
- Parallel: segments at coming from the same way. Minor form
177
B turns
Abrupt changes in B sheets. Glycine and proline help stabilize it. Four amino acids make up the turn, of which glycine and proline are present. Bond between 1st and 4th amino acid and 3rd and 4th amino acid
178
Non-repetitive sequences
Loops and coils
179
Super secondary structure (motifs)
2 or more secondary structures that are connected by loops or turns
- Helix-turn-helix: major groove binding
- Helix-bend-helix: TFs
- B barrels: antiparallel rolled up (bacterial pores)
- B hairpins: found in globular proteins
- Helix bundles: transmembrane proteins
180
Tertiary structure
Stabilized by ionic bonds, H bonds, hydrophobic interactions, and disulfide bridges
181
Quaternary structure
2 or more polypeptides
182
Protein denaturation
Disrupts the non-covalent interactions but not the covalent bonds (peptide and disulfide)
Denaturants: pH, heat, urea, organic solvents
183
Enzymes
Lower activation energy but don’t change delta G
184
Standard unit
1micromol/min.
This is how you measure enzyme activity since you can’t get molar amount of enzyme
185
Specific activity
IU/mg
Measure enzyme purity
186
Isoenzymes
Enzymes that catalyze the same reaction in different parts of the body
187
CK2
Isoenzyme found in cardiac tissue. Is a diagnosis marker for cardiac tissue damage since damage leads to a lot of CK2 release
188
Cofactors
Other substances needed to help in enzymatic activity
2 types:
- Inorganic
- Organic: coenzymes
189
Ribozymes
Non-protein enzymes that are made of RNA. Help catalyze peptide bond formation
190
Ribonuclearproteins
Made of RNA and nucleic acids.
Ex: telomerase
191
Proximity effect
Brings enzyme and substrates together
192
Orientation effect
Provides correct orientation for catalysis
193
Catalytic effect
Provides the correct functional groups (acidic, basic)
194
Energy effect
Helps reach transition state
195
Lock and key model
Substance fits directly into the enzyme.
Static model
196
Induced fit
Enzyme wraps around substance since they are not a perfect fit
Dynamic model
197
V max
Maximum rate that is achieved theoretically
198
Km
Substance concentration that reached 1/2 v max
199
Reversible inhibitors
Bind to enzyme through non-covalent interactions. If you add a diluted solution without inhibitors, inhibitors will be washed off
200
Irreversible inhibitors
Covalently binds to the enzyme. Adding the solution won’t wash off the inhibitors
Ex: lead and mercury bind to S on cysteine residues
Ex: malathion (organophosphorus insecticide) and sarin (nerve gas) inhibit acetylcholinesterase
201
Competitive inhibitors
Actively competes with the substrate to get to the active site. Higher substrate concentration will displace inhibitor. So max isn’t changed by km is increased
202
Lovastatin
Lovastatin inhibits HMG-CoA reductase (synthesizes cholesterols) to reduce cholesterol levels
Good for treatment of hypercholesterolemia
203
Non-competitive inhibitors
Binds to the enzyme at a different site than the active site. Leads to change in active site or getting rid of it altogether. Decereases vmax but km is the same
204
Transition state analogs
Mimics the 3D structure of the transition state but doesn’t form products. Bind very tightly to the active site
205
Suicide inhibitors
Binds to the enzyme but never leaves the active site
Ex: penicillin inhibits glycopeptice transpeptidase by modifying the serine chain -OH group
Ex: aspirin inhibits cyclooxygenase
Ex: allopurional inhibits xanthine oxidase
206
Changing enzyme amount
- Synthesis: slow
| - Proteolysis: fast and degrades
207
Changing enzyme activity
- Proteloysis
- Phosphorylation/dephosphorylation
- Cooperativity/alosteric regulation
208
Trypsinogen
In its inactive form. Be woke active by cleavage (proteolysis) or 6 amino acids. Active ones can then activate other inactive ones
209
Cooperativity
Usually when an enzyme has more than one subunit. One substrate binds to active site on one of the subunits and if it’s positive cooperativity rest of the substrates will bind as well.
Does not follow Michaelis-Mentin curve. Leads to a sigmoid also curve
210
Alosteric regulation
Effector binds to place outside of the active site and can be positive or negative effect.
When paired with Cooperativity, activators will stabilize the high energy state and make the curve more hyperbolic
211
V effector
Affects vmax parameter and is used when enzyme has higher enzyme concentration
212
Km effector
Affects km parameter and is used when enzyme has low substrate concentration
213
Adding phosphate by...
Protein kinase with the help of ATP
214
Taking away phosphate...
Phosphoprotein phosphatase
215
Protein kinase A
Ligand binds to membrane which sends secondary messenger (cAMP) which tells kinase to phosphorylate and become active. Kinase then works on multiple reaction pathways
216
Glycogen phosphorylase
When phosphorylated, increases activity
217
Glycogen synthase
When phosphorylated, decreases activity
218
Preparing agarose gel
- One gram of agarose in 50 ml of TBE buffer
- Microwave for 1-2 mins
- Put under running water
- Put in casting tray its comb and make sure there are no air bubbles
- Let it solidify
- Take out comb
219
PCR method
- Add MgCl2, taq polymerase, dNTP into lambda DNA and primers
- Centrifuge
- Add buffer dye (helps see DNA migration)
220
MgCL2
Helps in primer binding to DNA
221
Electrophoresis method
- Take 10 micro liters or marker and put in one well
- Put 20 microliters of sample in one well
- Run for 1 hr at 60 volts
- Look at results with UV trasilluminator camera
222
Sickle cell anemia
Point mutation in changing glutamate to valine. This makes it stay at the top of gel electrophoresis.
Mutation in B chain of hemoglobin
Normal:
- Oxygenated: nothin
- Deoxygenated: pockets
Mutated:
- oxygenatedm spikes
- Deoxygenated: spikes and pockets ( so forms clumps when low oxygen which leads to vessel clogging and leads to pain)
223
Prions
Change alpha helices to b sheets. Leads to rogue protein which can make enormous protein rogue as well
Exam mad cow disease, CFJ
224
Amyloid precursor protein
Not cleaved properly so leads to Alzheimer’s since plaques develop
225
Collagen synthesis
In the rough ER. Formed by C terminus and helped by inter and intra H bonds as well as disulfide bridges
In the extracellular space, N and C peptodases will cut off some of the N and C ends
226
Modification of collagen
- Hydroxylation of proline by proloyl hydroxylase with the help of vitamin C
- Fibril formation by covalent cross-linking of lysine helped by lysine oxidase. Need copper for this
227
OI
Change in glycine to a bulky amino acid will result in a weak and brittle collagen and no hydroxylation
228
EDH
Caused by mutation
229
UV radiation
Degrade collagen and forms wrinkles and premature aging
230
Metabolic pathways
All reactions in a cell
231
Cycles
Pathways that regenerate a substance
232
Catabolic pathways
Breaking down a high energy product (glucose) to a low energy product (CO2)
Produces ATP, NADH, and NADPH
High ATP closes catabolic pathways
233
Anabolic pathways
Building up high energy products from low energy products
Use ATP, NADH to provide energy for the buildup
High ATP open anabolic pathways
234
Break reactions into small steps
- Pathways will take place where the enzyme is
- Compartmentalized into organelles
- One product will be reactant of the next
235
Intrinsic regulation
Based on cells needs. Use ATP, ADP, NADPH, NADP+
236
Extrinsic regulation
Based on body’s needs. Use hormones
237
Free energy
Energy available to do work. When it’s negative, it’s spontaneous. At equilibrium, delta G is 0.
Can couple a nonspontaneous reaction to a spontaneous one
238
Phosphory-transfer potential
Ability to transfer a phosphate group. ATP has can both accept and donate a phosphate group
239
Redox reactions
Transferring electrons between substances
240
Redox potential
Wanting to gain electrons
241
Reducing equivalent
Substance that helps transfer electrons
NADH and NADPH are the come common ones
242
Committed step
First reaction in a pathway that is irreversible and has only one unique product. Also known as the rate-limiting step. It’s also the slowest step
243
Feedback inhibition
Product of a reaction will inhibit that same reaction
Advantages:
- Prevent accumulation of toxic waste
- Prevents wastage if energy
244
Feed forward reaction
A product early on in the reaction will activate an enzyme later on in the pathway
245
GLUT isoforms
Found on the membrane of cells and allows glucose to enter the cell
246
Glycolysis
Beginning of respiration if oxygen is available. If in anaerobic conditions, it’s the only way to get ATP
247
Changing glucose to G6P
Phosphorylate glucose using ATP with a hexokinase
This allows:
- Glucose to be be further metabolized since it was inert
- Prevents glucose from leaving the cell because now it’s an anion
NOT THE COMMITTED STEPPPP
248
Hexokinase
Found in non-hepatic cells
Has a low km so non-hepatic cells can trap glucose
Low vmax so can’t trap phosphorylated glucose or phosphorylate more glucose than it can use
249
Glucokinase
Found in the liver
Has high vmax for rapid uptake glucose from bloodstream, gkycogenesis, and prevents hyperglycaemia
Has high km fo rapid synthesis/release of glucose (can leave liver following a big meal), glycogenolysis, and prevents hypoglycemia
Induced by insulin
250
PFK1
Changes fructose 6 phosphate to fructose 1,6 biphosphate through phosphorylation
251
Aldose B
Cleaves fructose 1,6 biphosphate to glyceraldehyde 3 phosphate
252
Glyceraldehyde 3 phosphate dehydrogenase
Changes glyceraldehyde 3 phosphate to 1,3 biphosphoglycerate
This is the first oxidation reduction reaction and produce a NADH
253
Pyruvate kinase
Changes PEP to pyruvate and gain an ATP through substrate level phosphorylation
254
Branching of pyruvate
- Oxidative decarboxylation to acetyl CoA
- Reduction to lactate and ethanol
- Transformation to alanine
255
Regulation of hexokinase
Inhibited by G6P. So make sure that if there is a lot of glycolysis going on (meaning there will be a lot of energy) won’t waste any more glucose
256
Regulation of PFK1
Negative: ATP, citrate, H+ from lactate
Positive: fructose 2,6, biphosphate and AMP
257
Fructose 2,6, biphosphate
Most important regulator for PFK1. Not an intermediate of glycolysis. Catalysts by PFK-2
258
PFK2
Non-phosphorylation form catalyze fructose 2,6 biphosphate
Phosphorylated form: glucagon will bind to membrane causing cclyic aMP to activate protein kinase A which will phosphorylate PFK2. Liver stops consuming glucose and makes glucose (so opposite effect!)
In the heart, the phosphorylated form is active and vice versa
259
Regulation by pyruvate kinase
Negative: alanine, ATP
Positive: fructose 1,6 biphosphate: feed forward reaction
260
Fructose accumulation
When there’s an aldose B deficiency, accumulation of fructose and deficiency in ATP
Shouldn’t give people fructose or sucrose
261
Classic galactosemia
Deficiency of GLAT which changes galactose you glucose so accumulation of galactose and can’t make ATP
262
Get acetyl coA from...
- Pyruvate
- Fatty acids
- Proteins
263
Pyruvate dehydrogenase
Changes pyruvate to acetyl CoA
Need it to be inactivated so don’t need the protein kinase A
Positive: ATP, NADH
Negative: ADP, NAD+, CoA
264
Oxoacetate
Transports CoA to cell
265
Citrate
Can move in the mitochondria
ACETYL COA CANT MOVE INSIDE THE MITOCHONDRIA
266
Isocitrate dehydrogenase
Rate-limiting step
Negative: ATP and NADH
Positive: ADP, Ca
Uses both NAD and NADP
267
Succinyl coA
Metabolic branch point
268
Succinyl thiokinase
Makes the GTP
269
Succinate dehydrogenase
Complex II in mitochondria electron transport chain. Changes FAD to FADH2
270
Malaga dehydrogenase
Generates last NADH
271
Summary of Krebs cycle
- 2 carbons from acetyl CoA released as CO2
- Make 3 NADH
- 1 FADH2
- 1GTP
272
Regulation of Krebs cycle
- Citrate synthase inhibited by citrate
| - Allosteric regulators of cycle: Ca2+, ATP, ADP
273
Inner membrane of mitochondria
Not permeable to substances. Has five complexes
Four are for transferring electrons
One is for making ATP
Inner membrane is folded to allow the complexes to be on it
274
Intermembrane space
Has a lot of H+ ions
275
Matrix
Place where the hydrogen ions go
276
Electron transport chain
Electrons lost by NADH & FADH2 and go to oxygen and combine with hydrogen to form water
277
Oxidative phosphorylation
Using diffusion energy of H+ ions, can make ATP
278
Complex 1
NADH dehydrogenase. Has Fe-S centers, FMN, and coenzyme Q
Fe-S will transfer electrons from NADH to coenzyme Q
Allows proteins to go into the intermembrane space
279
Coenzyme Q (ubiquinone)
A benzoquinone which is hydrophobic.
Gets one electron to be a emiubiquinone radical and two to become ubiquinone
Small size allows for diffusion across the membrane.
Statin inhibits it’s synthesis
280
Flavoproteins
Contain FMN or FAD.
Accept one electron to become semiquinone and 2 to become FMNH2
Can donate two electrons to NAD+ and one to Fe
281
Fe-S
Contain 2-8 iron atoms that are complexes with elemental and cysteine S residues
Can only transfer one electron at a time
282
Complex 2
Succunate dehydrogenase (like in TCA). Has FAD and Fe-S clusters
Electrons from Coq are given to FAD which reduce it. FAD gives to Fe-S clusters who give it to another Coq
283
Complex 3
Cytochrome c reductase. Contains cytochrome c, b1, Coq.
Undergoes the Q cycle
284
Q cycle
Round 1: CoQ gives electron to Fe-S who gives it to to cytochrome c. Other electron goes to cytochrome b. At this time, CoQ will dock at cytochrome b point and receive this electron to become a radical
Round 2: Another CoQ will come and give electron to cytochrome c. Other will go to cytochrome b to give to quinone radical to become normal again
285
Cytochromes
Contain heme which can undergo transition between two iron states
286
Cytochrome c
Transfers electrons to complex 4. Has positive amino acids which interact with the negative amino acids in complex 4 which helps it dock
287
Complex 4
Cytochrome C will dock on complex 4 and Cu will accepts the electrons and give it to O one at a time
1 e: o radical
2 e: peroxide
3 e: 2 o radical
4 e: water
288
Moving H
Complexes will have strong affinity for H in the beginning and then have low affinity which will allow it to release it
289
Complex 5
Makes ATP
Has two parts: F1 and F0
290
F0
Has a rod (a subunit) and rotating part (c subunit). Protons go up rod and are repelled by c subunit. End of c subunit when bound to rod will allows hydrogen ions to exit leading to a step movement
291
F1
In the matrix and makes ATP
Has 3 catalytic sites
Site 1: has ADP and pi
Site 2: has ATP
Site 3: empty
Every rotation is 120 degrees to repeat the cycle after every three rotations
292
Uncouplers
Lipid-soluble molecules that will dissipate the electrochemical gradient of H+. H ions will still move but instead of energy being in ATP, it’ll be in heat
Thermogenein (UCP1) is an example
UCP2 and UCP3 lead to weight loss by breaking down fat
293
Mitochondrial diseases
From mother. Random selection of mitochondria region leads to some areas having more infectious agents than others
294
Glycogen
Stores glucose. Is a branches polysaccharide that is sparsely soluble
Has glycosidic type a 1,4 and 1,6 bonds
Found in liver and muscle. Higher composition in liver but higher mass in muscles.
Muscle glycogen can not give glucose to other tissues since it doesn’t have glucose 6 phosphorylase
295
Phosphoglucomuatse
Isomerizes glucose 6 phosphate to glucose 1 phosphate
296
Glycogen synthase
Adds glucose to 4’ end on glycogen branch. However, this is thermodynamically unfavorable so first has reaction with UTP and glycogen synthase uses this phosphate to add glucose
Glycogen synthase can only add glucose to an already existing glycogen chain
297
If no glycogen chain...
Glucose attaches to tyrosine residue on glycogenin. Glycogenin catalyzes it’s own reaction
After about 7 chains, glycogen synthase can begin acting on it
298
Branching enzyme
Takes a residue of about 6-7 branches and attaches it to a terminal carbon 6 group to form an a 1,6 bond
299
Glycogen phosphorylase
Breaks down glycogen to form glucose. Cannot break down a glycogen chain that is 4 residues or less
300
Debranching enzyme
Breaks down the 4 chain glycogen molecule. Takes three out of the four glucose molecules and adds them to a longer chain. Takes the remaining one and cuts off the bond to form a free glucose molecule
301
Lysosomal degradation of glucose
Lysosome has enzymes to break down glycogen. However, breaks down a very negligible amount.
When this enzyme is defected, glycogen accumulates in the lysosome vesicle and leads to glycogen storage disease type II (pompe’s disease)
302
Regulation of glycogen phosphorylase
When blood glucose becomes low, glucagon levels become high. So glucagon binds to the receptor and form cAMP. cAMP will activate protein kinase A. PKA will activate the active “a” form of phosphorylase kinase. “A” form of phosphorylase kinase will activate glycogen phosphorylase and break down glycogen
In muscle, epinephrine is used
303
A adrenergic receptors
Couple to adenyl cyclase and form cAMP
304
B adrenergic receptors
Coupled to G protein. G protein activates phospholipase C. Phospholipase C hydrolyzes PIP2 to form IP3 and DAG
DAG binds to & activates protein kinase C that phosphorylates a lot of molecules including glycogen synthase
IP3 binds to ER receptors to release Ca. Ca will bind with calmodulin and activate phosphorylase kinase
305
In liver, epinephrine...
Leads to same Ca cascade
306
In muscle, acetylcholine
Will release Ca and go through same cascade. In this way, don’t need pka to activate phosphorylase kinase
AMP also activated phosphorylase kinase
307
Glycogen synthase
Exits in active “a” non-phosphorylated form and inactive “b” phosphorylated form
Insulin will activate glycogen synthase and glucagon will inhibit it
308
Pentose phosphate pathway
Anabolic reaction that changes 6 carbon sugar (glucose) to 5 carbon sugar (ribose) for nucleotide and nucleic acid synthesis
Also makes NADPH and makes glyceraldehyde-3-phosphate and glucose-6 phosphate
Has 2 steps:
- Oxidative
- Non oxidative
309
Oxidative
G6P is changed to 6-phosphogluconate and produces NADPH
6-phosphogluconate is changed to ribulose-5 phosphate and produces NADPH
310
NADPH
Differs from NADH by one phosphate group. Involved in anabolic reactions
Need it for:
- Synthesis of fatty acids and cholesterol
- Changing ribonucleotides to deoxyribonucleotides
- Reducing glutathione (antioxidant)
311
Non-oxidative stage
- Change ribulose 5P to ribose 5P (make NADPH)
| - Make glyceraldehyde 3-phosphate and G6P (to go back to oxidative stage and g9 to glycolysis) (also makes NADPH)
312
Digesting proteins in stomach
- HCl: secreted by parietal cells and first denatures and then cleaves
- Pepsinogen: gets activated by active pepsin and HCl
313
Digestion by pancreas
Zymogens released by cholecystokinin and secretin
Activated by:
- Enteropeptidase activates trypsinogen
- Trpsinogen activates everything else
314
Digestion in small intestine
Done by aminopeptidase which is an exopeptidase the is found in the lumenal surface of the intestine. Repeatedly cleaves N-terminus from oligopeptides to form smaller peptides and amino acids
315
Absorbing free amino acids
Through Na+ linked secondary transport system in RBCs
316
Absorbing di- and tri- peptides
Through a H+ transport system
317
Cystinuria
Defect in transport system in proximal tubules of kidney to absorb cysteine. Leads to accumulation of cysteine leading to stones in the urinary tract
